BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 16, 2009
View Archived Issues
Rosuvastatin reduces high sensitivity C-reactive protein and LDLC
Read More
Effects of bivalirudin in HORIZONS-AMI trial independent of clopidogrel dose
Read More
Novel MEK inhibitors identified by Curis
Read More
Abbott describes novel prodrugs of a histamine H3 receptor ligand
Read More
T-type calcium channel inhibitors claimed by Ewha Womans University as analgesics
Read More
Boehringer Ingelheim claims novel calcitonin gene-related peptide antagonists
Read More
Arete Therapeutics presents epoxide hydrolase inhibitors for the treatment of hypertension
Read More
First human pharmacokinetic data for anticancer agent KP-1019 reported
Read More
Merck & Co. and Santen enter licensing agreement for tafluprost
Read More
Pro-Pharmaceuticals' Davanat was not associated with mucositis in phase I and II trials
Read More
Pfizer and Medivation initiate phase III trial of Dimebon added to donepezil in AD patients
Read More
Novel corticotropin-releasing factor receptor antagonists developed as anxiolytics
Read More
Cannasat and IntelGenx report phase Ib results for buccal dronabinol
Read More
Etanercept to be studied in Kawasaki disease / News in Context
Read More
Infinity stops RING trial in advanced GIST, clinical trials to continue in other cancers
Read More
Novagali completes phase II Cyclokat trial in dry eye
Read More
Vyteris and Zealand Pharma sign collaboration agreement in transdermal peptide delivery
Read More
Tekmira files IND with FDA for phase I clinical trial of ApoB SNALP for LDL cholesterol
Read More
Asahi Kasei and Dong-A sign license agreement for BPH drug Flivas
Read More
XenoPort exercises co-promotion option contained in agreement with GSK for Solzira
Read More
Accera forms wholly owned subsidiary, Neuera Pharmaceuticals
Read More
Sirion reports interim phase II results for fenretinide
Read More
Ensemble forms alliance with Bristol-Myers Squibb to develop novel drug class
Read More
Cangene to supply the U.S. Department of Defense with VIG vaccine
Read More
Clinuvel provides update on afamelanotide
Read More